Dragan Lovic

TL;DR: In this article, a group of experts from the European Society of Hypertension and invited neurologists discuss the main reasons for the discrepancies in the current evidence on the prognosis and treatment of altered BP in acute ischemic stroke.

TL;DR: In patients with stabilized CHD, comorbid conditions that may reflect the ubiquitous nature of atherosclerosis, dominate lifestyle-related and other modifiable risk factors in terms of prognosis, at least over a 2-year follow-up period.

TL;DR: Optimized guidelines adherence is more cost-effective in higher risk patients, in patients with higher risk reductions and when using a less strict LDL-C target.

TL;DR: The basis of therapy for hypertension in MS lies in a changed way of life, involving caloric intake reduction, increased quality of food, increased physical activity, and medicamentous therapy, which has a favorable impact not only on blood pressure, but on all the components of MS, and is able to delay the onset of diabetes.